看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。8 P% ?9 ^6 s m
* ^3 P8 I0 D' m) H( c. {
. j( U8 Z6 t2 [ f. E# ICurrently available feasibility data for possible combination strategies.
4 P3 c/ A: B; S3 Z————————————————————————————————
& f T, X V4 ^! O$ M/ I5 g, e2 nCombination Feasibility according to preliminary data 3 g0 {: B ^9 J6 n" Z+ Y: t8 F
——————————————————————————————————( s( ~) I: A9 m1 c R) Z3 [
Bevacizumab + sorafenib Yes, reduced dose
3 {0 e0 _2 B% N. I: h; mBevacizumab + sunitinib† No
8 C0 f& v1 q3 ~! n/ } zBevacizumab + temsirolimus Yes
$ e# g) B, H% ] O" rBevacizumab + everolimus Yes
8 Y2 `- [8 l" J& GSorafenib + sunitinib ?
2 I' |" o* E7 wSorafenib + temsirolimus Yes, reduced dose : Q3 J J- [% T4 L& n5 g/ s2 [
Sorafenib + everolimus Yes, reduced dose 2 J. M2 M# q( B* E! E
Sunitinib + temsirolimus† No
* r) w7 A: g% Q0 V/ i; aSunitinib + everolimus ?
( [# D u. }* [. V& Y+ QTemsirolimus + everolimus ?
* R( U7 A: P0 T————————————————————) w4 F, d5 A& X; Q
†Led to US FDA warning.
0 S) L! U& f( S- X$ \! T, j/ ^2 Y?: As yet unattempted combination.& A; S. D1 f" j7 w& W0 G/ W- c4 ^) ~% b
|